论文部分内容阅读
目的观察丹参酮ⅡA磺酸钠治疗脑梗塞的临床疗效。方法将100例脑梗塞患者随机分为红花对照组和丹参酮ⅡA磺酸钠治疗组,两组均为14天为一个疗程,一个疗程后统计疗效。结果治疗组总有效率93.1%,对照组总有效率76.01%,治疗组优于对照组。结论丹参酮ⅡA磺酸钠具有安全、疗效肯定的优点,是治疗急性缺血性脑梗塞的有效药物。
Objective To observe the clinical effect of tanshinone Ⅱ A sulfonate on cerebral infarction. Methods 100 cases of cerebral infarction were randomly divided into safflower control group and tanshinone Ⅱ A sodium sulfonate treatment group, both groups were 14 days for a course of treatment, a course of treatment after statistical effect. Results The total effective rate was 93.1% in the treatment group and 76.01% in the control group, and the treatment group was superior to the control group. Conclusion Sodium tanshinone Ⅱ A sulfonate has the advantages of safety and curative effect, and is an effective drug for the treatment of acute ischemic cerebral infarction.